FDA grants accelerated approval to Gavreto for advanced or metastatic RET-altered thyroid cancers Dec. 2, 2020
FDA approves Imcivree as first-ever therapy for POMC, PCSK1 or LEPR deficiency obesities Nov. 30, 2020
FDA approves Zokinvy for Hutchinson-Gilford progeria syndrome and progeroid laminopathies Nov. 24, 2020
RSS